Methylene Blue
Morning with food
Methylene blue is a synthetic compound originally developed as a textile dye in 1876, later adopted in medicine as a treatment for methemoglobinemia and malaria. At very low doses (0.5–2 mg/kg), it acts as an electron carrier in mitochondria and has been investigated for potential cognitive and neuroprotective effects. It remains primarily a pharmaceutical agent with limited evidence supporting its use as a general supplement.
Research Evidence
Treats methemoglobinemia as an FDA-approved medical intervention
StrongMay improve short-term memory and attention in healthy adults
LimitedPotential neuroprotective effects in neurodegenerative disease models
LimitedMay enhance mitochondrial electron transport and cellular energy production at low doses
ModerateAntimalarial activity against Plasmodium falciparum
ModerateExpert Evidence
15 references from 3 experts
2025
Safety & Cautions
Side Effects
- Blue-green discoloration of urine and body fluids
- Gastrointestinal upset and nausea
- Risk of serotonin syndrome when combined with serotonergic medications
- Potential DNA intercalation at higher doses
- Skin and oral staining
Methylene blue carries serious drug interaction risks, particularly serotonin syndrome when taken with SSRIs, SNRIs, MAOIs, or other serotonergic agents. Multiple medical experts have expressed reservations about supplemental use given the lack of robust human randomized controlled trials and concerns about mutagenic potential from DNA intercalation.
Pairs Well With
